pd0348292
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00306254)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor XINHIBITOR
F10 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide
- pd0348292
- pd 0348292
- pd 0348292
- pd 0348292
- pd-0348292
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00306254 | Phase 2 | Mar 1, 2006 | Pfizer |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 1 | 1 | 1 | 2006 |
1 organizations
Page 1 / 1